Literature DB >> 31548312

Serine 474 phosphorylation is essential for maximal Akt2 kinase activity in adipocytes.

Alison L Kearney1, Kristen C Cooke1, Dougall M Norris1, Armella Zadoorian1, James R Krycer1, Daniel J Fazakerley2, James G Burchfield3, David E James4,5.   

Abstract

The Ser/Thr protein kinase Akt regulates essential biological processes such as cell survival, growth, and metabolism. Upon growth factor stimulation, Akt is phosphorylated at Ser474; however, how this phosphorylation contributes to Akt activation remains controversial. Previous studies, which induced loss of Ser474 phosphorylation by ablating its upstream kinase mTORC2, have implicated Ser474 phosphorylation as a driver of Akt substrate specificity. Here we directly studied the role of Akt2 Ser474 phosphorylation in 3T3-L1 adipocytes by preventing Ser474 phosphorylation without perturbing mTORC2 activity. This was achieved by utilizing a chemical genetics approach, where ectopically expressed S474A Akt2 was engineered with a W80A mutation to confer resistance to the Akt inhibitor MK2206, and thus allow its activation independent of endogenous Akt. We found that insulin-stimulated phosphorylation of four bona fide Akt substrates (TSC2, PRAS40, FOXO1/3a, and AS160) was reduced by ∼50% in the absence of Ser474 phosphorylation. Accordingly, insulin-stimulated mTORC1 activation, protein synthesis, FOXO nuclear exclusion, GLUT4 translocation, and glucose uptake were attenuated upon loss of Ser474 phosphorylation. We propose a model where Ser474 phosphorylation is required for maximal Akt2 kinase activity in adipocytes.
© 2019 Kearney et al.

Entities:  

Keywords:  Akt PKB; Akt Ser474 phosphorylation; Akt W80A; GLUT4; MK2206; adipocyte; cell signaling; chemical genetics; glucose transport; insulin; mTOR complex (mTORC); phosphorylation; protein synthesis; serine/threonine protein kinase; substrate specificity

Mesh:

Substances:

Year:  2019        PMID: 31548312      PMCID: PMC6851323          DOI: 10.1074/jbc.RA119.010036

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  PDK1 selectively phosphorylates Thr(308) on Akt and contributes to human platelet functional responses.

Authors:  C Dangelmaier; B K Manne; E Liverani; J Jin; P Bray; S P Kunapuli
Journal:  Thromb Haemost       Date:  2013-12-19       Impact factor: 5.249

2.  SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity.

Authors:  Estela Jacinto; Valeria Facchinetti; Dou Liu; Nelyn Soto; Shiniu Wei; Sung Yun Jung; Qiaojia Huang; Jun Qin; Bing Su
Journal:  Cell       Date:  2006-09-07       Impact factor: 41.582

Review 3.  Muscle and adipose tissue insulin resistance: malady without mechanism?

Authors:  Daniel J Fazakerley; James R Krycer; Alison L Kearney; Samantha L Hocking; David E James
Journal:  J Lipid Res       Date:  2018-07-27       Impact factor: 5.922

Review 4.  Recent development of anticancer therapeutics targeting Akt.

Authors:  John K Morrow; Lei Du-Cuny; Lu Chen; Emmanuelle J Meuillet; Eugene A Mash; Garth Powis; Shuxing Zhang
Journal:  Recent Pat Anticancer Drug Discov       Date:  2011-01       Impact factor: 4.169

5.  Deficiency of PDK1 in liver results in glucose intolerance, impairment of insulin-regulated gene expression and liver failure.

Authors:  Alfonso Mora; Christopher Lipina; François Tronche; Calum Sutherland; Dario R Alessi
Journal:  Biochem J       Date:  2005-02-01       Impact factor: 3.857

6.  An allosteric Akt inhibitor effectively blocks Akt signaling and tumor growth with only transient effects on glucose and insulin levels in vivo.

Authors:  Craig Cherrin; Kathleen Haskell; Bonnie Howell; Raymond Jones; Karen Leander; Ronald Robinson; Aubrey Watkins; Mark Bilodeau; Jacob Hoffman; Philip Sanderson; George Hartman; Elizabeth Mahan; Thomayant Prueksaritanont; Guoqiang Jiang; Qing-Bai She; Neal Rosen; Laura Sepp-Lorenzino; Deborah Defeo-Jones; Hans E Huber
Journal:  Cancer Biol Ther       Date:  2010-04-01       Impact factor: 4.742

7.  Alternative Activation Mechanisms of Protein Kinase B Trigger Distinct Downstream Signaling Responses.

Authors:  Deborah Balzano; Mohamad-Ali Fawal; Jose V Velázquez; Clara M Santiveri; Joshua Yang; Joaquín Pastor; Ramón Campos-Olivas; Nabil Djouder; Daniel Lietha
Journal:  J Biol Chem       Date:  2015-08-18       Impact factor: 5.157

8.  IRS1-independent defects define major nodes of insulin resistance.

Authors:  Kyle L Hoehn; Cordula Hohnen-Behrens; Anna Cederberg; Lindsay E Wu; Nigel Turner; Tomoyuki Yuasa; Yousuke Ebina; David E James
Journal:  Cell Metab       Date:  2008-05       Impact factor: 27.287

9.  Kinetics of insulin action on protein synthesis in isolated adipocytes. Ability of glucose to selectively desensitize the glucose transport system without altering insulin stimulation of protein synthesis.

Authors:  S Marshall
Journal:  J Biol Chem       Date:  1989-02-05       Impact factor: 5.157

10.  Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism.

Authors:  Yuefeng Tang; Martina Wallace; Joan Sanchez-Gurmaches; Wen-Yu Hsiao; Huawei Li; Peter L Lee; Santiago Vernia; Christian M Metallo; David A Guertin
Journal:  Nat Commun       Date:  2016-04-21       Impact factor: 14.919

View more
  14 in total

1.  Insulin signaling requires glucose to promote lipid anabolism in adipocytes.

Authors:  James R Krycer; Lake-Ee Quek; Deanne Francis; Armella Zadoorian; Fiona C Weiss; Kristen C Cooke; Marin E Nelson; Alexis Diaz-Vegas; Sean J Humphrey; Richard Scalzo; Akiyoshi Hirayama; Satsuki Ikeda; Futaba Shoji; Kumi Suzuki; Kevin Huynh; Corey Giles; Bianca Varney; Shilpa R Nagarajan; Andrew J Hoy; Tomoyoshi Soga; Peter J Meikle; Gregory J Cooney; Daniel J Fazakerley; David E James
Journal:  J Biol Chem       Date:  2020-07-28       Impact factor: 5.157

2.  Dissecting the biology of mTORC1 beyond rapamycin.

Authors:  Guang Yang; Deanne Francis; James R Krycer; Mark Larance; Ziyang Zhang; Chris J Novotny; Alexis Diaz-Vegas; Kevan M Shokat; David E James
Journal:  Sci Signal       Date:  2021-09-21       Impact factor: 8.192

Review 3.  Integrating adipocyte insulin signaling and metabolism in the multi-omics era.

Authors:  C Martinez Calejman; W G Doxsey; D J Fazakerley; D A Guertin
Journal:  Trends Biochem Sci       Date:  2022-03-15       Impact factor: 14.264

4.  Branched-chain ketoacid overload inhibits insulin action in the muscle.

Authors:  Dipsikha Biswas; Khoi T Dao; Angella Mercer; Andrew M Cowie; Luke Duffley; Yassine El Hiani; Petra C Kienesberger; Thomas Pulinilkunnil
Journal:  J Biol Chem       Date:  2020-09-02       Impact factor: 5.157

5.  Proteome and Phosphoproteome Analysis of Brown Adipocytes Reveals That RICTOR Loss Dampens Global Insulin/AKT Signaling.

Authors:  Samuel W Entwisle; Camila Martinez Calejman; Anthony S Valente; Robert T Lawrence; Chien-Min Hung; David A Guertin; Judit Villén
Journal:  Mol Cell Proteomics       Date:  2020-03-31       Impact factor: 5.911

Review 6.  Control of Akt activity and substrate phosphorylation in cells.

Authors:  Ivan Yudushkin
Journal:  IUBMB Life       Date:  2020-03-03       Impact factor: 3.885

7.  Akt phosphorylates insulin receptor substrate to limit PI3K-mediated PIP3 synthesis.

Authors:  Alison L Kearney; Dougall M Norris; Milad Ghomlaghi; Martin Kin Lok Wong; Sean J Humphrey; Luke Carroll; Guang Yang; Kristen C Cooke; Pengyi Yang; Thomas A Geddes; Sungyoung Shin; Daniel J Fazakerley; Lan K Nguyen; David E James; James G Burchfield
Journal:  Elife       Date:  2021-07-13       Impact factor: 8.140

8.  Exercise effects on γ3-AMPK activity, phosphorylation of Akt2 and AS160, and insulin-stimulated glucose uptake in insulin-resistant rat skeletal muscle.

Authors:  Mark W Pataky; Edward B Arias; Haiyan Wang; Xiaohua Zheng; Gregory D Cartee
Journal:  J Appl Physiol (1985)       Date:  2020-01-16

9.  Global redox proteome and phosphoproteome analysis reveals redox switch in Akt.

Authors:  Zhiduan Su; James G Burchfield; Pengyi Yang; Sean J Humphrey; Guang Yang; Deanne Francis; Sabina Yasmin; Sung-Young Shin; Dougall M Norris; Alison L Kearney; Miro A Astore; Jonathan Scavuzzo; Kelsey H Fisher-Wellman; Qiao-Ping Wang; Benjamin L Parker; G Gregory Neely; Fatemeh Vafaee; Joyce Chiu; Reichelle Yeo; Philip J Hogg; Daniel J Fazakerley; Lan K Nguyen; Serdar Kuyucak; David E James
Journal:  Nat Commun       Date:  2019-12-02       Impact factor: 14.919

Review 10.  Regulation of mTORC2 Signaling.

Authors:  Wenxiang Fu; Michael N Hall
Journal:  Genes (Basel)       Date:  2020-09-04       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.